{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:46:26Z","timestamp":1789973186749,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clnu.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T21:06:07Z","timestamp":1459631167000},"page":"1386-1393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Bj\u00f8rg","family":"Sj\u00f8blom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn H.","family":"Gr\u00f8nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Wentzel-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie E.","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne J.","family":"Hjermstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Aass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Bremnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fl\u00f8tten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Bye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Jordh\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnu.2016.03.010_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clnu.2016.03.010_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","article-title":"Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey","volume":"5","author":"Morgensztern","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2016.03.010_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjc.6603869","article-title":"Vinorelbine\/carboplatin vs gemcitabine\/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity","volume":"97","author":"Helbekkmo","year":"2007","journal-title":"Br J Cancer"},{"issue":"19","key":"10.1016\/j.clnu.2016.03.010_bib4","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1200\/JCO.2008.20.9114","article-title":"Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer","volume":"27","author":"Gronberg","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2016.03.010_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/bjc.2012.284","article-title":"Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group","volume":"107","author":"Flotten","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnu.2016.03.010_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/CMAR.S63603","article-title":"A\u00a0comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer","volume":"6","author":"Cuyun Carter","year":"2014","journal-title":"Cancer Manag Res"},{"issue":"8","key":"10.1016\/j.clnu.2016.03.010_bib7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clnu.2016.03.010_bib8","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2016.03.010_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.010_bib10","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","author":"Kazemi-Bajestani","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.clnu.2016.03.010_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00520-014-2418-6","article-title":"Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy","volume":"23","author":"Jung","year":"2015","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.clnu.2016.03.010_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.clnu.2016.03.010_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.clnu.2016.03.010_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clnu.2016.03.010_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bjs.7823","article-title":"Body composition and outcome in patients undergoing resection of colorectal liver metastases","volume":"99","author":"van Vledder","year":"2012","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.clnu.2016.03.010_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/10428194.2013.816421","article-title":"Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"55","author":"Lanic","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.clnu.2016.03.010_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.clnu.2016.03.010_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40279-015-0305-z","article-title":"Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment","volume":"45","author":"Fragala","year":"2015","journal-title":"Sports Med"},{"issue":"3","key":"10.1016\/j.clnu.2016.03.010_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/apha.12224","article-title":"Measurement of skeletal muscle radiation attenuation and basis of its biological variation","volume":"210","author":"Aubrey","year":"2014","journal-title":"Acta Physiol Oxf Engl"},{"issue":"13","key":"10.1016\/j.clnu.2016.03.010_bib20","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.clnu.2016.03.010_bib21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00268-012-1581-5","article-title":"Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma","volume":"36","author":"Miller","year":"2012","journal-title":"World J Surg"},{"issue":"18","key":"10.1016\/j.clnu.2016.03.010_bib22","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.28218","article-title":"Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies","volume":"119","author":"Antoun","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clnu.2016.03.010_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.clnu.2016.03.010_bib24","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J\u00a0Appl Physiol (Bethesda, Md 1985)"},{"issue":"5","key":"10.1016\/j.clnu.2016.03.010_bib25","doi-asserted-by":"crossref","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.clnu.2016.03.010_bib26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clnu.2015.08.005","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","volume":"35","author":"Rollins","year":"2016","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2016.03.010_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","article-title":"Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content","volume":"89","author":"Goodpaster","year":"2000","journal-title":"J\u00a0Appl Physiol (Bethesda, Md 1985)"},{"issue":"3","key":"10.1016\/j.clnu.2016.03.010_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCO.0b013e328337d826","article-title":"Epidemiology of myosteatosis","volume":"13","author":"Miljkovic","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"10.1016\/j.clnu.2016.03.010_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Stephens","year":"2011","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.clnu.2016.03.010_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.clnu.2016.03.010_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/SLA.0000000000001113","article-title":"Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer","volume":"263","author":"Malietzis","year":"2016","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.clnu.2016.03.010_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/clpt.2011.122","article-title":"Use of inflammatory markers to guide cancer treatment","volume":"90","author":"Clarke","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"22","key":"10.1016\/j.clnu.2016.03.010_bib33","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.clnu.2016.03.010_bib34","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s11605-013-2348-5","article-title":"Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies","volume":"17","author":"Dodson","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.clnu.2016.03.010_bib35","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1245\/s10434-014-4281-6","article-title":"Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer","volume":"22","author":"Miyamoto","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clnu.2016.03.010_bib36","doi-asserted-by":"crossref","first-page":"e0129742","DOI":"10.1371\/journal.pone.0129742","article-title":"Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer","volume":"10","author":"Miyamoto","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnu.2016.03.010_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","article-title":"Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study","volume":"44","author":"Dalal","year":"2012","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"5","key":"10.1016\/j.clnu.2016.03.010_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1556-0864(15)31609-9","article-title":"Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594","volume":"1","author":"Wakelee","year":"2006","journal-title":"J\u00a0Thorac Oncol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561416001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561416001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T02:12:31Z","timestamp":1567735951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561416001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0261561416001011"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2016.03.010","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}